nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0632	0.0797	CbGbCtD
Triazolam—CYP3A7—Tamoxifen—pancreatic cancer	0.0632	0.0797	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0486	0.0612	CbGbCtD
Triazolam—CYP3A7—Irinotecan—pancreatic cancer	0.0486	0.0612	CbGbCtD
Triazolam—CYP3A5—Tamoxifen—pancreatic cancer	0.0474	0.0598	CbGbCtD
Triazolam—CYP2C8—Tamoxifen—pancreatic cancer	0.0456	0.0575	CbGbCtD
Triazolam—CYP3A5—Erlotinib—pancreatic cancer	0.0403	0.0508	CbGbCtD
Triazolam—CYP2C8—Erlotinib—pancreatic cancer	0.0388	0.0489	CbGbCtD
Triazolam—CYP3A5—Irinotecan—pancreatic cancer	0.0364	0.0459	CbGbCtD
Triazolam—CYP3A7—Docetaxel—pancreatic cancer	0.0356	0.0449	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0356	0.0449	CbGbCtD
Triazolam—CYP3A7—Sunitinib—pancreatic cancer	0.0354	0.0447	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0354	0.0447	CbGbCtD
Triazolam—CYP2C8—Fluorouracil—pancreatic cancer	0.0336	0.0424	CbGbCtD
Triazolam—CYP2C9—Tamoxifen—pancreatic cancer	0.0318	0.0401	CbGbCtD
Triazolam—CYP3A5—Docetaxel—pancreatic cancer	0.0267	0.0337	CbGbCtD
Triazolam—CYP3A5—Sunitinib—pancreatic cancer	0.0266	0.0335	CbGbCtD
Triazolam—CYP2C9—Fluorouracil—pancreatic cancer	0.0234	0.0296	CbGbCtD
Triazolam—CYP3A4—Tamoxifen—pancreatic cancer	0.0185	0.0233	CbGbCtD
Triazolam—CYP3A4—Erlotinib—pancreatic cancer	0.0157	0.0198	CbGbCtD
Triazolam—CYP3A4—Irinotecan—pancreatic cancer	0.0142	0.0179	CbGbCtD
Triazolam—CYP3A4—Docetaxel—pancreatic cancer	0.0104	0.0131	CbGbCtD
Triazolam—CYP3A4—Sunitinib—pancreatic cancer	0.0104	0.0131	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—pancreatic cancer	0.00776	0.00978	CbGbCtD
Triazolam—Malaise—Gemcitabine—pancreatic cancer	0.000537	0.00259	CcSEcCtD
Triazolam—Hypertension—Irinotecan—pancreatic cancer	0.000527	0.00255	CcSEcCtD
Triazolam—Stomatitis—Docetaxel—pancreatic cancer	0.000527	0.00255	CcSEcCtD
Triazolam—Jaundice—Docetaxel—pancreatic cancer	0.000527	0.00255	CcSEcCtD
Triazolam—Hepatic failure—Epirubicin—pancreatic cancer	0.000526	0.00254	CcSEcCtD
Triazolam—Decreased appetite—Sunitinib—pancreatic cancer	0.000526	0.00254	CcSEcCtD
Triazolam—Mental disability—Doxorubicin—pancreatic cancer	0.000523	0.00253	CcSEcCtD
Triazolam—Fatigue—Sunitinib—pancreatic cancer	0.000522	0.00252	CcSEcCtD
Triazolam—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000521	0.00252	CcSEcCtD
Triazolam—Constipation—Sunitinib—pancreatic cancer	0.000518	0.0025	CcSEcCtD
Triazolam—Pain—Sunitinib—pancreatic cancer	0.000518	0.0025	CcSEcCtD
Triazolam—Discomfort—Irinotecan—pancreatic cancer	0.000514	0.00248	CcSEcCtD
Triazolam—Hypertension—Gemcitabine—pancreatic cancer	0.000514	0.00248	CcSEcCtD
Triazolam—Asthenia—Tamoxifen—pancreatic cancer	0.000507	0.00245	CcSEcCtD
Triazolam—Chest pain—Gemcitabine—pancreatic cancer	0.000507	0.00245	CcSEcCtD
Triazolam—Confusional state—Irinotecan—pancreatic cancer	0.000503	0.00243	CcSEcCtD
Triazolam—Asthenia—Erlotinib—pancreatic cancer	0.000502	0.00243	CcSEcCtD
Triazolam—Discomfort—Gemcitabine—pancreatic cancer	0.000501	0.00242	CcSEcCtD
Triazolam—Pruritus—Tamoxifen—pancreatic cancer	0.0005	0.00242	CcSEcCtD
Triazolam—Oedema—Irinotecan—pancreatic cancer	0.000499	0.00241	CcSEcCtD
Triazolam—Chest pain—Fluorouracil—pancreatic cancer	0.000498	0.00241	CcSEcCtD
Triazolam—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000495	0.00239	CcSEcCtD
Triazolam—Pruritus—Erlotinib—pancreatic cancer	0.000495	0.00239	CcSEcCtD
Triazolam—Discomfort—Fluorouracil—pancreatic cancer	0.000492	0.00238	CcSEcCtD
Triazolam—Shock—Irinotecan—pancreatic cancer	0.00049	0.00237	CcSEcCtD
Triazolam—Hepatic failure—Doxorubicin—pancreatic cancer	0.000487	0.00235	CcSEcCtD
Triazolam—Oedema—Gemcitabine—pancreatic cancer	0.000486	0.00235	CcSEcCtD
Triazolam—Diarrhoea—Tamoxifen—pancreatic cancer	0.000483	0.00234	CcSEcCtD
Triazolam—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000482	0.00233	CcSEcCtD
Triazolam—Confusional state—Fluorouracil—pancreatic cancer	0.000481	0.00233	CcSEcCtD
Triazolam—Abdominal pain—Sunitinib—pancreatic cancer	0.000478	0.00231	CcSEcCtD
Triazolam—Diarrhoea—Erlotinib—pancreatic cancer	0.000478	0.00231	CcSEcCtD
Triazolam—Oedema—Fluorouracil—pancreatic cancer	0.000477	0.00231	CcSEcCtD
Triazolam—Anorexia—Irinotecan—pancreatic cancer	0.000475	0.0023	CcSEcCtD
Triazolam—Osteoarthritis—Epirubicin—pancreatic cancer	0.000473	0.00229	CcSEcCtD
Triazolam—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000469	0.00227	CcSEcCtD
Triazolam—Visual impairment—Docetaxel—pancreatic cancer	0.000467	0.00226	CcSEcCtD
Triazolam—Dizziness—Tamoxifen—pancreatic cancer	0.000467	0.00226	CcSEcCtD
Triazolam—Tachycardia—Fluorouracil—pancreatic cancer	0.000466	0.00225	CcSEcCtD
Triazolam—Affect lability—Epirubicin—pancreatic cancer	0.000466	0.00225	CcSEcCtD
Triazolam—Anorexia—Gemcitabine—pancreatic cancer	0.000463	0.00224	CcSEcCtD
Triazolam—Dizziness—Erlotinib—pancreatic cancer	0.000462	0.00224	CcSEcCtD
Triazolam—Anorexia—Fluorouracil—pancreatic cancer	0.000455	0.0022	CcSEcCtD
Triazolam—Insomnia—Irinotecan—pancreatic cancer	0.000451	0.00218	CcSEcCtD
Triazolam—Vomiting—Tamoxifen—pancreatic cancer	0.000449	0.00217	CcSEcCtD
Triazolam—Mood swings—Epirubicin—pancreatic cancer	0.000448	0.00217	CcSEcCtD
Triazolam—Paraesthesia—Irinotecan—pancreatic cancer	0.000448	0.00216	CcSEcCtD
Triazolam—Hypersensitivity—Sunitinib—pancreatic cancer	0.000446	0.00216	CcSEcCtD
Triazolam—Dermatitis—Tamoxifen—pancreatic cancer	0.000445	0.00215	CcSEcCtD
Triazolam—Ataxia—Epirubicin—pancreatic cancer	0.000445	0.00215	CcSEcCtD
Triazolam—Vomiting—Erlotinib—pancreatic cancer	0.000445	0.00215	CcSEcCtD
Triazolam—Dyspnoea—Irinotecan—pancreatic cancer	0.000444	0.00215	CcSEcCtD
Triazolam—Somnolence—Irinotecan—pancreatic cancer	0.000443	0.00214	CcSEcCtD
Triazolam—Headache—Tamoxifen—pancreatic cancer	0.000443	0.00214	CcSEcCtD
Triazolam—Dermatitis—Erlotinib—pancreatic cancer	0.00044	0.00213	CcSEcCtD
Triazolam—Insomnia—Gemcitabine—pancreatic cancer	0.000439	0.00212	CcSEcCtD
Triazolam—Headache—Erlotinib—pancreatic cancer	0.000438	0.00212	CcSEcCtD
Triazolam—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000438	0.00212	CcSEcCtD
Triazolam—Paraesthesia—Gemcitabine—pancreatic cancer	0.000436	0.00211	CcSEcCtD
Triazolam—Asthenia—Sunitinib—pancreatic cancer	0.000434	0.0021	CcSEcCtD
Triazolam—Decreased appetite—Irinotecan—pancreatic cancer	0.000433	0.0021	CcSEcCtD
Triazolam—Dyspnoea—Gemcitabine—pancreatic cancer	0.000433	0.00209	CcSEcCtD
Triazolam—Insomnia—Fluorouracil—pancreatic cancer	0.000432	0.00209	CcSEcCtD
Triazolam—Somnolence—Gemcitabine—pancreatic cancer	0.000432	0.00209	CcSEcCtD
Triazolam—Affect lability—Doxorubicin—pancreatic cancer	0.000431	0.00208	CcSEcCtD
Triazolam—Fatigue—Irinotecan—pancreatic cancer	0.00043	0.00208	CcSEcCtD
Triazolam—Paraesthesia—Fluorouracil—pancreatic cancer	0.000429	0.00207	CcSEcCtD
Triazolam—Pruritus—Sunitinib—pancreatic cancer	0.000428	0.00207	CcSEcCtD
Triazolam—Pain—Irinotecan—pancreatic cancer	0.000426	0.00206	CcSEcCtD
Triazolam—Constipation—Irinotecan—pancreatic cancer	0.000426	0.00206	CcSEcCtD
Triazolam—Dyspnoea—Fluorouracil—pancreatic cancer	0.000426	0.00206	CcSEcCtD
Triazolam—Somnolence—Fluorouracil—pancreatic cancer	0.000424	0.00205	CcSEcCtD
Triazolam—Erythema—Docetaxel—pancreatic cancer	0.000422	0.00204	CcSEcCtD
Triazolam—Decreased appetite—Gemcitabine—pancreatic cancer	0.000422	0.00204	CcSEcCtD
Triazolam—Nausea—Tamoxifen—pancreatic cancer	0.00042	0.00203	CcSEcCtD
Triazolam—Fatigue—Gemcitabine—pancreatic cancer	0.000419	0.00202	CcSEcCtD
Triazolam—Muscular weakness—Epirubicin—pancreatic cancer	0.000417	0.00202	CcSEcCtD
Triazolam—Pain—Gemcitabine—pancreatic cancer	0.000415	0.00201	CcSEcCtD
Triazolam—Constipation—Gemcitabine—pancreatic cancer	0.000415	0.00201	CcSEcCtD
Triazolam—Nausea—Erlotinib—pancreatic cancer	0.000415	0.00201	CcSEcCtD
Triazolam—Decreased appetite—Fluorouracil—pancreatic cancer	0.000415	0.00201	CcSEcCtD
Triazolam—Mood swings—Doxorubicin—pancreatic cancer	0.000415	0.002	CcSEcCtD
Triazolam—Diarrhoea—Sunitinib—pancreatic cancer	0.000414	0.002	CcSEcCtD
Triazolam—Dysgeusia—Docetaxel—pancreatic cancer	0.000414	0.002	CcSEcCtD
Triazolam—Ataxia—Doxorubicin—pancreatic cancer	0.000411	0.00199	CcSEcCtD
Triazolam—Feeling abnormal—Irinotecan—pancreatic cancer	0.000411	0.00199	CcSEcCtD
Triazolam—Pain—Fluorouracil—pancreatic cancer	0.000408	0.00197	CcSEcCtD
Triazolam—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000408	0.00197	CcSEcCtD
Triazolam—Muscle spasms—Docetaxel—pancreatic cancer	0.000406	0.00196	CcSEcCtD
Triazolam—Dizziness—Sunitinib—pancreatic cancer	0.0004	0.00194	CcSEcCtD
Triazolam—Feeling abnormal—Gemcitabine—pancreatic cancer	0.0004	0.00194	CcSEcCtD
Triazolam—Abdominal pain—Irinotecan—pancreatic cancer	0.000394	0.00191	CcSEcCtD
Triazolam—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000393	0.0019	CcSEcCtD
Triazolam—Muscular weakness—Doxorubicin—pancreatic cancer	0.000386	0.00187	CcSEcCtD
Triazolam—Vomiting—Sunitinib—pancreatic cancer	0.000385	0.00186	CcSEcCtD
Triazolam—Dysuria—Epirubicin—pancreatic cancer	0.000382	0.00185	CcSEcCtD
Triazolam—Dermatitis—Sunitinib—pancreatic cancer	0.000381	0.00184	CcSEcCtD
Triazolam—Headache—Sunitinib—pancreatic cancer	0.000379	0.00183	CcSEcCtD
Triazolam—Syncope—Docetaxel—pancreatic cancer	0.000379	0.00183	CcSEcCtD
Triazolam—Palpitations—Docetaxel—pancreatic cancer	0.000373	0.0018	CcSEcCtD
Triazolam—Loss of consciousness—Docetaxel—pancreatic cancer	0.000371	0.00179	CcSEcCtD
Triazolam—Hypersensitivity—Irinotecan—pancreatic cancer	0.000367	0.00178	CcSEcCtD
Triazolam—Hypertension—Docetaxel—pancreatic cancer	0.000365	0.00176	CcSEcCtD
Triazolam—Drowsiness—Epirubicin—pancreatic cancer	0.000364	0.00176	CcSEcCtD
Triazolam—Chest pain—Docetaxel—pancreatic cancer	0.00036	0.00174	CcSEcCtD
Triazolam—Nausea—Sunitinib—pancreatic cancer	0.000359	0.00174	CcSEcCtD
Triazolam—Asthenia—Irinotecan—pancreatic cancer	0.000358	0.00173	CcSEcCtD
Triazolam—Stomatitis—Epirubicin—pancreatic cancer	0.000355	0.00172	CcSEcCtD
Triazolam—Jaundice—Epirubicin—pancreatic cancer	0.000355	0.00172	CcSEcCtD
Triazolam—Dysuria—Doxorubicin—pancreatic cancer	0.000354	0.00171	CcSEcCtD
Triazolam—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000352	0.0017	CcSEcCtD
Triazolam—Dry mouth—Docetaxel—pancreatic cancer	0.000352	0.0017	CcSEcCtD
Triazolam—Asthenia—Gemcitabine—pancreatic cancer	0.000348	0.00168	CcSEcCtD
Triazolam—Confusional state—Docetaxel—pancreatic cancer	0.000347	0.00168	CcSEcCtD
Triazolam—Oedema—Docetaxel—pancreatic cancer	0.000345	0.00167	CcSEcCtD
Triazolam—Pruritus—Gemcitabine—pancreatic cancer	0.000344	0.00166	CcSEcCtD
Triazolam—Diarrhoea—Irinotecan—pancreatic cancer	0.000341	0.00165	CcSEcCtD
Triazolam—Shock—Docetaxel—pancreatic cancer	0.000339	0.00164	CcSEcCtD
Triazolam—Pruritus—Fluorouracil—pancreatic cancer	0.000338	0.00163	CcSEcCtD
Triazolam—Drowsiness—Doxorubicin—pancreatic cancer	0.000337	0.00163	CcSEcCtD
Triazolam—Tachycardia—Docetaxel—pancreatic cancer	0.000336	0.00163	CcSEcCtD
Triazolam—Diarrhoea—Gemcitabine—pancreatic cancer	0.000332	0.00161	CcSEcCtD
Triazolam—Dizziness—Irinotecan—pancreatic cancer	0.00033	0.00159	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—pancreatic cancer	0.000329	0.00159	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—pancreatic cancer	0.000329	0.00159	CcSEcCtD
Triazolam—Anorexia—Docetaxel—pancreatic cancer	0.000329	0.00159	CcSEcCtD
Triazolam—Diarrhoea—Fluorouracil—pancreatic cancer	0.000327	0.00158	CcSEcCtD
Triazolam—Vomiting—Irinotecan—pancreatic cancer	0.000317	0.00153	CcSEcCtD
Triazolam—Dizziness—Fluorouracil—pancreatic cancer	0.000316	0.00153	CcSEcCtD
Triazolam—Visual impairment—Epirubicin—pancreatic cancer	0.000315	0.00152	CcSEcCtD
Triazolam—Dermatitis—Irinotecan—pancreatic cancer	0.000314	0.00152	CcSEcCtD
Triazolam—Headache—Irinotecan—pancreatic cancer	0.000312	0.00151	CcSEcCtD
Triazolam—Insomnia—Docetaxel—pancreatic cancer	0.000312	0.00151	CcSEcCtD
Triazolam—Paraesthesia—Docetaxel—pancreatic cancer	0.000309	0.0015	CcSEcCtD
Triazolam—Vomiting—Gemcitabine—pancreatic cancer	0.000309	0.00149	CcSEcCtD
Triazolam—Dyspnoea—Docetaxel—pancreatic cancer	0.000307	0.00149	CcSEcCtD
Triazolam—Somnolence—Docetaxel—pancreatic cancer	0.000306	0.00148	CcSEcCtD
Triazolam—Dermatitis—Gemcitabine—pancreatic cancer	0.000306	0.00148	CcSEcCtD
Triazolam—Tinnitus—Epirubicin—pancreatic cancer	0.000305	0.00148	CcSEcCtD
Triazolam—Headache—Gemcitabine—pancreatic cancer	0.000304	0.00147	CcSEcCtD
Triazolam—Vomiting—Fluorouracil—pancreatic cancer	0.000304	0.00147	CcSEcCtD
Triazolam—Dermatitis—Fluorouracil—pancreatic cancer	0.000301	0.00145	CcSEcCtD
Triazolam—Decreased appetite—Docetaxel—pancreatic cancer	0.0003	0.00145	CcSEcCtD
Triazolam—Headache—Fluorouracil—pancreatic cancer	0.000299	0.00145	CcSEcCtD
Triazolam—Fatigue—Docetaxel—pancreatic cancer	0.000297	0.00144	CcSEcCtD
Triazolam—Nausea—Irinotecan—pancreatic cancer	0.000296	0.00143	CcSEcCtD
Triazolam—Pain—Docetaxel—pancreatic cancer	0.000295	0.00143	CcSEcCtD
Triazolam—Constipation—Docetaxel—pancreatic cancer	0.000295	0.00143	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—pancreatic cancer	0.000292	0.00141	CcSEcCtD
Triazolam—Nausea—Gemcitabine—pancreatic cancer	0.000288	0.00139	CcSEcCtD
Triazolam—Erythema—Epirubicin—pancreatic cancer	0.000285	0.00138	CcSEcCtD
Triazolam—Feeling abnormal—Docetaxel—pancreatic cancer	0.000284	0.00137	CcSEcCtD
Triazolam—Nausea—Fluorouracil—pancreatic cancer	0.000284	0.00137	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—pancreatic cancer	0.000282	0.00136	CcSEcCtD
Triazolam—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000282	0.00136	CcSEcCtD
Triazolam—Flatulence—Epirubicin—pancreatic cancer	0.000281	0.00136	CcSEcCtD
Triazolam—Tension—Epirubicin—pancreatic cancer	0.000279	0.00135	CcSEcCtD
Triazolam—Dysgeusia—Epirubicin—pancreatic cancer	0.000279	0.00135	CcSEcCtD
Triazolam—Nervousness—Epirubicin—pancreatic cancer	0.000277	0.00134	CcSEcCtD
Triazolam—Muscle spasms—Epirubicin—pancreatic cancer	0.000274	0.00132	CcSEcCtD
Triazolam—Abdominal pain—Docetaxel—pancreatic cancer	0.000272	0.00132	CcSEcCtD
Triazolam—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000264	0.00128	CcSEcCtD
Triazolam—Erythema—Doxorubicin—pancreatic cancer	0.000264	0.00127	CcSEcCtD
Triazolam—Agitation—Epirubicin—pancreatic cancer	0.000262	0.00127	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—pancreatic cancer	0.00026	0.00126	CcSEcCtD
Triazolam—Tension—Doxorubicin—pancreatic cancer	0.000259	0.00125	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—pancreatic cancer	0.000258	0.00125	CcSEcCtD
Triazolam—Malaise—Epirubicin—pancreatic cancer	0.000257	0.00124	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—pancreatic cancer	0.000256	0.00124	CcSEcCtD
Triazolam—Syncope—Epirubicin—pancreatic cancer	0.000255	0.00124	CcSEcCtD
Triazolam—Hypersensitivity—Docetaxel—pancreatic cancer	0.000254	0.00123	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—pancreatic cancer	0.000253	0.00123	CcSEcCtD
Triazolam—Palpitations—Epirubicin—pancreatic cancer	0.000252	0.00122	CcSEcCtD
Triazolam—Loss of consciousness—Epirubicin—pancreatic cancer	0.00025	0.00121	CcSEcCtD
Triazolam—Asthenia—Docetaxel—pancreatic cancer	0.000247	0.0012	CcSEcCtD
Triazolam—Hypertension—Epirubicin—pancreatic cancer	0.000246	0.00119	CcSEcCtD
Triazolam—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000245	0.00118	CcSEcCtD
Triazolam—Pruritus—Docetaxel—pancreatic cancer	0.000244	0.00118	CcSEcCtD
Triazolam—Chest pain—Epirubicin—pancreatic cancer	0.000242	0.00117	CcSEcCtD
Triazolam—Agitation—Doxorubicin—pancreatic cancer	0.000242	0.00117	CcSEcCtD
Triazolam—Anxiety—Epirubicin—pancreatic cancer	0.000242	0.00117	CcSEcCtD
Triazolam—Discomfort—Epirubicin—pancreatic cancer	0.00024	0.00116	CcSEcCtD
Triazolam—Malaise—Doxorubicin—pancreatic cancer	0.000238	0.00115	CcSEcCtD
Triazolam—Dry mouth—Epirubicin—pancreatic cancer	0.000237	0.00115	CcSEcCtD
Triazolam—Syncope—Doxorubicin—pancreatic cancer	0.000236	0.00114	CcSEcCtD
Triazolam—Diarrhoea—Docetaxel—pancreatic cancer	0.000236	0.00114	CcSEcCtD
Triazolam—Confusional state—Epirubicin—pancreatic cancer	0.000234	0.00113	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—pancreatic cancer	0.000233	0.00113	CcSEcCtD
Triazolam—Oedema—Epirubicin—pancreatic cancer	0.000232	0.00112	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000232	0.00112	CcSEcCtD
Triazolam—Shock—Epirubicin—pancreatic cancer	0.000229	0.00111	CcSEcCtD
Triazolam—Dizziness—Docetaxel—pancreatic cancer	0.000228	0.0011	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—pancreatic cancer	0.000228	0.0011	CcSEcCtD
Triazolam—Tachycardia—Epirubicin—pancreatic cancer	0.000227	0.0011	CcSEcCtD
Triazolam—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000225	0.00109	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—pancreatic cancer	0.000224	0.00108	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—pancreatic cancer	0.000224	0.00108	CcSEcCtD
Triazolam—Discomfort—Doxorubicin—pancreatic cancer	0.000222	0.00107	CcSEcCtD
Triazolam—Anorexia—Epirubicin—pancreatic cancer	0.000222	0.00107	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—pancreatic cancer	0.000219	0.00106	CcSEcCtD
Triazolam—Vomiting—Docetaxel—pancreatic cancer	0.000219	0.00106	CcSEcCtD
Triazolam—Dermatitis—Docetaxel—pancreatic cancer	0.000217	0.00105	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—pancreatic cancer	0.000217	0.00105	CcSEcCtD
Triazolam—Headache—Docetaxel—pancreatic cancer	0.000216	0.00104	CcSEcCtD
Triazolam—Oedema—Doxorubicin—pancreatic cancer	0.000215	0.00104	CcSEcCtD
Triazolam—Shock—Doxorubicin—pancreatic cancer	0.000212	0.00102	CcSEcCtD
Triazolam—Insomnia—Epirubicin—pancreatic cancer	0.00021	0.00102	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—pancreatic cancer	0.00021	0.00102	CcSEcCtD
Triazolam—Paraesthesia—Epirubicin—pancreatic cancer	0.000209	0.00101	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000208	0.00101	CcSEcCtD
Triazolam—Dyspnoea—Epirubicin—pancreatic cancer	0.000207	0.001	CcSEcCtD
Triazolam—Somnolence—Epirubicin—pancreatic cancer	0.000207	0.000999	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—pancreatic cancer	0.000205	0.000991	CcSEcCtD
Triazolam—Nausea—Docetaxel—pancreatic cancer	0.000205	0.00099	CcSEcCtD
Triazolam—Decreased appetite—Epirubicin—pancreatic cancer	0.000202	0.000977	CcSEcCtD
Triazolam—Fatigue—Epirubicin—pancreatic cancer	0.0002	0.000969	CcSEcCtD
Triazolam—Pain—Epirubicin—pancreatic cancer	0.000199	0.000961	CcSEcCtD
Triazolam—Constipation—Epirubicin—pancreatic cancer	0.000199	0.000961	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—pancreatic cancer	0.000195	0.000941	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—pancreatic cancer	0.000193	0.000934	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—pancreatic cancer	0.000192	0.000927	CcSEcCtD
Triazolam—Feeling abnormal—Epirubicin—pancreatic cancer	0.000192	0.000926	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—pancreatic cancer	0.000191	0.000925	CcSEcCtD
Triazolam—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00019	0.000919	CcSEcCtD
Triazolam—Decreased appetite—Doxorubicin—pancreatic cancer	0.000187	0.000904	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—pancreatic cancer	0.000185	0.000897	CcSEcCtD
Triazolam—Pain—Doxorubicin—pancreatic cancer	0.000184	0.000889	CcSEcCtD
Triazolam—Constipation—Doxorubicin—pancreatic cancer	0.000184	0.000889	CcSEcCtD
Triazolam—Abdominal pain—Epirubicin—pancreatic cancer	0.000184	0.000889	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000177	0.000857	CcSEcCtD
Triazolam—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000176	0.00085	CcSEcCtD
Triazolam—Hypersensitivity—Epirubicin—pancreatic cancer	0.000171	0.000828	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—pancreatic cancer	0.00017	0.000822	CcSEcCtD
Triazolam—Asthenia—Epirubicin—pancreatic cancer	0.000167	0.000806	CcSEcCtD
Triazolam—Pruritus—Epirubicin—pancreatic cancer	0.000164	0.000795	CcSEcCtD
Triazolam—Diarrhoea—Epirubicin—pancreatic cancer	0.000159	0.000769	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000158	0.000766	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—pancreatic cancer	0.000154	0.000746	CcSEcCtD
Triazolam—Dizziness—Epirubicin—pancreatic cancer	0.000154	0.000743	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—pancreatic cancer	0.000152	0.000736	CcSEcCtD
Triazolam—Vomiting—Epirubicin—pancreatic cancer	0.000148	0.000715	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—pancreatic cancer	0.000147	0.000712	CcSEcCtD
Triazolam—Dermatitis—Epirubicin—pancreatic cancer	0.000146	0.000708	CcSEcCtD
Triazolam—Headache—Epirubicin—pancreatic cancer	0.000146	0.000704	CcSEcCtD
Triazolam—Dizziness—Doxorubicin—pancreatic cancer	0.000142	0.000688	CcSEcCtD
Triazolam—Nausea—Epirubicin—pancreatic cancer	0.000138	0.000668	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—pancreatic cancer	0.000137	0.000661	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—pancreatic cancer	0.000135	0.000655	CcSEcCtD
Triazolam—Headache—Doxorubicin—pancreatic cancer	0.000135	0.000652	CcSEcCtD
Triazolam—Nausea—Doxorubicin—pancreatic cancer	0.000128	0.000618	CcSEcCtD
